brochure 3 to 5 october - nalccon 2020
TRANSCRIPT
2020
NAL ON10th Annual Conference of Indian Society for Study of Lung Cancer
th th 26 - 27 September 2020 rd th3 & 4 October 2020
STREAMING LIVE ON
A VIRTUAL PLATFORM
HALL A
Time Topic Speaker/Panelist Moderator/Chairperson
0400 - 0430 PMCase based discussion on locally
advanced lung cancer
Panelists -
Dr T Raja, Chennai
Dr Tarun Batra, Varanasi
Dr Promila Pankaj, Delhi
Dr Kanika Sood, Delhi
Dr Puneet Gupta, Noida
Moderator- Dr Charu
Garg, Delhi
0430 - 0445 PMPACIFIC Trial – Did it change the
practiceDr Sonam Puri, San Diego Dr P K Julka, Delhi
Dr Naresh Somani, Jaipur
Dr Hemant Malhotra, Jaipur0445 - 0500 PMParaneoplastic syndrome –
theoretical or is it practical Dr Abhishek Gulia, Delhi
Supported by Roche
0500 - 0530 PM
IMpower150: Atezolizumab plus
Bevacizumab plus chemotherapy –
First Line – Who Why When
Dr Ullas Batra, Delhi
Dr Vineet Talwar, Delhi
0530 - 0600 PM
Clinical Untility of Hybrid capture
based Liquid biopsy in Lung
Cancer
Dr Jeffery Ross, USA
0600 - 0615 PM
Adeno or Squam or
Adenosquam – Jumbled words or
biology: 1st line chemotherapy
for ADENO, SQUAM and
ADENOSQUAM
Dr T P Sahoo, BhopalDr Ashok K Vaid, Gurgaon
Dr Bharat Bhosle, Mumbai
0615 - 0645 PM
Supported by Astra Zeneca
Experience sharing on
Durvalumab for the Management
of stage III unresectable NSCLC
Dr Daniel Chan, Singapore
Expert Comments
Dr S H Advani, MumbaiOsimertinib adjuvant therapy in
patients (pts) with resected EGFR
mutated (EGFRm) NSCLC
(ADAURA)
Dr Bharat Vaswani, Hyderabad
2020
NAL ONScientic Program
rdSaturday, 3 October 2020
HALL A
Time Topic Speaker/Panelist Moderator/Chairperson
0645 - 0700 PM
ADENOCARCINOMA –
TARGETS- COST limitations –
what to do
Dr Sewanti Limaye, Mumbai
Dr Meenu Walia, Delhi
Dr Shyam Aggarwal, Delhi
Dr Ajay Bapna, Jaipur0700 - 0715 PM
ADENOCARCINOMA – TARGETS –
not EGFR ALK AND NOT ROS1:
CHEMOTHERAPY and targets how to
choose how to sequence
Dr. Vikas Talreja, Delhi
0715 - 0730 PMSmall cell LUNG cancer: Cost and
Immunotherapy – benefit, if yes to
whom, where does it really help
Dr Prabhat Malik, Delhi
0730 - 0800 PM Survivor Ship for Lung Cancer Mr Vivek Tomar, Patient Advocate
2020
NAL ONScientic Program
rdSaturday, 3 October 2020
2020
NAL ONScientic Program
rdSaturday, 3 October 2020HALL B
Time Topic Speaker/Panelist Moderator/Chairperson
0400 - 0430 PM Case based discussion on locally advanced lung cancer in Hall A
0430 - 0445 PMRadiation Induced Lung Injury in
world of IO Dr Anil Tibdewal, Mumbai Dr Munish Gairola, Delhi
Dr Sushma Agrawal,
Lucknow0445 - 0500 PM Adaptive RT in Lung Cancer Dr. Shyam Bisth
0500 - 0600 PM Roche Sponsored Session in Hall A
0600 - 0615 PM
Adeno or Squam or Adenosquam –
Jumbled words or biology: First line
IO for ADENO, SQUAM AND
ADENOSQUAM with or chemo that
is the question
Dr Anita Ramesh, ChennaiDr Bijesh Raj Ghimire,
Nepal
0615 - 0645 PM Astra Zeneca Sponsored Session in Hall A
0645 - 0700 PM
ADENOCARCINOMA – NO
TARGETS Cost no limitations –
what to do
Dr Chirag Desai, Ahemdabad
Dr Kaustav Talpatre,
Mumbai0700 - 0715 PM
ADENOCARCINOMA – TARGETS
– not EGFR ALK AND NOT ROS1:
Immunotherapy how to choose
how to sequence
Dr Amit Rauthan, Bangalore
0715 - 0730 PM
Small cell LUNG cancer: Role of
consolidation in extensive stage –
who, when and how
Dr Pranav Chadha, Mumbai
0730 - 0800 PM Survivor Ship for Lung Cancer in Hall A
HALL A
Time Topic Speaker/Panelist Moderator/Chairperson
0400 - 0430 PMCase based discussion on pleural
effusion
Panelists -
Dr Ashish Kr Aggarwall, UP
Dr Pankaj Chhabra, Haryana
Dr Peeyush Bajpai, Delhi
Dr Gopal Sharma, Delhi
Dr Sarvanna R, Coimbatore
Dr Vivek Saxena, Delhi
Moderator -
Dr Vivek Nangia, Delhi
Palliative Care
0430 - 0445 PMCough & Breathlessness– what to
do when all things failDr Nandini Vallath, Delhi
Dr Jayita Deodhar,
Mumbai
Dr Nevin Kishore, Delhi0445 - 0500 PM
When to counsel family about
end of life 10 days before or
100 days before
Dr Mary Ann Muckaden,
Mumbai
0500 - 0515 PMCord compression – Panel
Discussion
Panelists -
Dr Sushma Bhatnagar, Delhi
Dr Ritesh Sharma, Delhi
Dr Akshay Tiwari, Delhi
Dr V Srinivasan, Chennai
Moderator -
Dr Naveen Salins, Manipal
Supported by Astra Zeneca
0515 - 0545 PMOptimal management of EGFRm
metastatic NSCLC patientDr Suresh Ramalingam, USA
Moderator -
Dr Nitesh Rohatgi, Delhi
Chairperson -
Dr R Ranga Rao, Gurugram
Dr Shyam Aggarwal, Delhi
2020
NAL ONScientic Program
thSunday, 4 October 2020
2020
NAL ONScientic Program
thSunday, 4 October 2020HALL A
Time Topic Speaker/Panelist Moderator/Chairperson
Supported by Pfizer
0545 - 0615 PMALK – Lorlatinib – Do we have
a One Size Fits All drugDr Sanjay Popat, UK
Moderator -
Dr Nitesh Rohatgi, Delhi
Chairperson -
Dr R Ranga Rao, Gurugram
Dr Shyam Aggarwal, Delhi
0615 - 0630 PM
Whats ur choice - Neoadjuvant
Chemo Theraphy vs Neoajuvant
CTRT for lung Cancer
Dr Manish Singhal, Delhi
Dr Anusheel Munshi, DelhiDr. P K Julka
0630 - 0645 PMManagement of Lung toxicity in
the era of ImmunotherapyDr G S Bhattacharya, Kolkata
0645 - 0700 PMWhat are the must take away
from AYURVEDIC scienceDr Geeta Krishna, Gurugram Dr Nitesh Rohatgi, Delhi
0700 - 0730 PM ORAL POSTERS and 1 L prize
Dr D Behera
Dr Arun Goel/ Dr Munish
Gairola
Supported by Pfizer
0730 - 0800 PM EGFR TKI in the next 5 years Dr Tony Mok, Hong Kong
Dr D Behera, Chandigarh
Dr Navneet Singh, Chandigarh
Dr Harit Chaturvedi, Delhi
2020
NAL ONScientic Program
thSunday, 4 October 2020HALL B
Time Topic Speaker/Panelist Moderator/Chairperson
0400 - 0430 PM Case based discussion on pleural effusion in Hall A
Palliative Care
0430 - 0445 PMHaemoptysis in Lung Cancer –
Options/managementDr Rajiv Goyal, Delhi
Dr Manish Pandey, Delhi
Dr Sharad Joshi, Delhi0445 - 0500 PM
SVC obstruction – you don’t
suspect you wont findDr Shaleen Agrawal, Delhi
0500 - 0515 PM Cord compression - Panel Discussion in Hall A
0515 - 0545 PM Astra Zeneca Sponsored Session in Hall A
0545 - 0615 PM Pfizer Sponsored Session in Hall A
0615 - 0630 PMRole of Adjuvant CT/TKIs – post
SBRT/lobectomyDr Senthil Rajappa, Hyderabad
Dr Palanki Satya
Dattatreya, Hyderabad
0630 - 0645 PMHow to judge a good from a
bad BIOSIMILAR Dr K Govind Babu, Bangalore
0645 - 0700 PM5 practice changing takes form
last 5 yearsDr B K Smruti, Mumbai
0700 - 0730 PM ORAL POSTERS and 1 L prize in Hall A
0730 - 0800 PM Pfizer Sponsored Session in Hall A
OFFICIAL VIRTUAL MEETING PARTNER